Eloxx Pharmaceuticals Statistics
Total Valuation
ELOX has a market cap or net worth of $2.73 million. The enterprise value is $3.76 million.
| Market Cap | 2.73M |
| Enterprise Value | 3.76M |
Important Dates
The last earnings date was Thursday, November 9, 2023, after market close.
| Earnings Date | Nov 9, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
ELOX has 3.14 million shares outstanding. The number of shares has increased by 26.83% in one year.
| Shares Outstanding | 3.14M |
| Shares Change (YoY) | +26.83% |
| Shares Change (QoQ) | +24.20% |
| Owned by Insiders (%) | 0.41% |
| Owned by Institutions (%) | 18.50% |
| Float | 2.78M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.24
| Current Ratio | 0.24 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.65 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -338.99% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.14M |
| Employee Count | 18 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ELOX has paid $1.37 million in taxes.
| Income Tax | 1.37M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.21% in the last 52 weeks. The beta is 2.76, so ELOX's price volatility has been higher than the market average.
| Beta (1Y) | 2.76 |
| 52-Week Price Change | -88.21% |
| 50-Day Moving Average | 0.92 |
| 200-Day Moving Average | 2.62 |
| Relative Strength Index (RSI) | 35.37 |
| Average Volume (30 Days) | 9,424 |
Short Selling Information
The latest short interest is 21,485, so 0.68% of the outstanding shares have been sold short.
| Short Interest | 21,485 |
| Short Previous Month | 42,744 |
| Short % of Shares Out | 0.68% |
| Short % of Float | 0.77% |
| Short Ratio (days to cover) | 0.66 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.29M |
| Pretax Income | -20.48M |
| Net Income | -20.48M |
| EBITDA | -18.33M |
| EBIT | -19.06M |
| Earnings Per Share (EPS) | -$9.07 |
Balance Sheet
The company has $4.78 million in cash and $5.76 million in debt, giving a net cash position of -$983,000 or -$0.31 per share.
| Cash & Cash Equivalents | 4.78M |
| Total Debt | 5.76M |
| Net Cash | -983,000 |
| Net Cash Per Share | -$0.31 |
| Equity / Book Value | -20.05M |
| Book Value Per Share | -6.38 |
| Working Capital | -17.84M |
Cash Flow
| Operating Cash Flow | -17.99M |
| Capital Expenditures | n/a |
| Free Cash Flow | -17.99M |
| FCF Per Share | -$6.55 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ELOX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.83% |
| Shareholder Yield | -26.83% |
| Earnings Yield | -738.85% |
| FCF Yield | -648.99% |
Analyst Forecast
The average price target for ELOX is $55.00, which is 6,221.84% higher than the current price. The consensus rating is "Buy".
| Price Target | $55.00 |
| Price Target Difference | 6,221.84% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 2, 2022. It was a reverse split with a ratio of 1:40.
| Last Split Date | Dec 2, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |